PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia

Gynecologic Oncology

Volumn 109, Issue 1, 2008, Pages 59-64

  Fambrini, Massimiliano ^a   Penna, Carlo ^a   Pieralli, Annalisa ^a   Bussani, Cecilia ^a   Fallani, Maria Grazia ^a   Andersson, Karin L ^a   Scarselli, Gianfranco ^a   Marchionni, Mauro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CIN; Follow up; HPV; Self collected urine

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER RISK; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT CANCER; RISK FACTOR; SENSITIVITY AND SPECIFICITY; URINALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; WART VIRUS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 40949151513     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.12.032     Document Type: Article

References (34)

1. Pinto A., and Crum C.P. Natural history of cervical neoplasia: defining progression and its consequences. Clin Obstet Gynecol 43 (2000) 352-362
2. Mathevet P., Chemali E., Roy M., and Dargent D. Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP. Eur J Obstet Gynecol Reprod Biol 106 (2003) 214-218
3. Milojkovic M. Residual and recurrent lesions after conization for cervical intraepithelial neoplasia grade 3. Int J Gynaecol Obstet 76 (2002) 49-53
4. Narducci F., Occelli B., Boman F., Vinatier D., and Leroy J.L. Positive margins after conization and risk of persistent lesion. Gynecol Oncol 76 (2000) 311-314
5. Skjeldestad F.E., Hagen B., Lie A.K., and Isaksen C. Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 90 (1997) 428-433
6. Gardeil F., Barry-Walsh C., Prendiville W., Clinch J., and Turner M.J. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade II. Obstet Gynecol 89 (1997) 419-422
7. Penna C., Fambrini M., Fallani M.G., Pieralli A., Scarselli G., and Marchionni M. Laser CO2 conization in postmenopausal age: risk of cervical stenosis and unsatisfactory follow-up. Gynecol Oncol 96 3 (2005) 771-775
8. Nobbenhuis M., Meijer C., van den Brule A., Rozendaal L., Voorhorst F., Risse E., et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84 (2001) 796-801
9. Bollen L.J., Tjong-A-Hung S.P., and van der Velden J. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 72 (1999) 199-201
10. Bigrigg A., Haffenden D.K., Sheehan A.L., Codling B.W., and Read M.D. Efficacy and safety of large loop excision of the transformation zone. Lancet 343 (1994) 32-34
11. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 1 (1999) 12-19
12. Nagai Y., Maehama T., Asato T., and Kanazawa K. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?. Gynecol Oncol 79 2 (2000) 294-299
13. Jain S., Tseng C.J., Horng S.G., Soong Y.K., and Pao C.C. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 82 1 (Jul 2001) 177-180
14. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y., et al. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 190 4 (2004) 1046-1051
15. Alonso I., Torne A., Puig-Tintore L.M., Esteve R., Quinto L., Campo E., et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 103 2 (2006) 631-636
16. Gupta A., Arora R., Gupta S., Prusty B.K., Kailash U., Batra S., et al. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. J Clin Virol 37 3 (2006) 190-194
17. Daponte A., Pournaras S., Mademtzis I., Hadjichristodoulou C., Kostopoulou E., Maniatis A.N., et al. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol 36 3 (2006) 189-193
18. Prusty B.K., Kumar A., Arora R., Batra S., and Das B.C. Human papillomavirus (HPV) DNA detection in self-collected urine. Int J Gynaecol Obstet 90 3 (2005) 223-227
19. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 16 (2002) 2114-2119
20. Walker P., Dexeus S., De Palo G., Barrasso R., Campion M., Girardi F., et al. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 101 1 (2003) 175-177
21. Arbyn M., Paraskevaidis E., Martin-Hirsch P., Prendiville W., and Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 99 3 Suppl 1 (2005) S7-S11
22. Coupé V., Berkhof J., Verheijen R., and Meijer C. Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia. BJOG 114 (2007) 416-424
23. Ueda M., Ueki K., Kanemura M., Izuma S., Yamaguchi H., Nishiyama K., et al. Diagnostic and therapeutic laser conization for cervical intraepithelial neoplasia. Gynecol Oncol 101 1 (2006) 143-146
24. Reich O., Lahousen M., Pickel H., Tamussino K., and Winter R. Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins. Obstet Gynecol 99 2 (2002) 193-196
25. Lu C.H., Liu F.S., Kuo C.J., Chang C.C., and Ho E.S. Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia III. Obstet Gynecol 107 4 (2006) 830-835
26. Das B.C., Gopalkrishna V., Sharma J.K., Roy M., and Luthra U.K. Human papillomavirus DNA in urine of women with preneoplastic and neoplastic cervical lesions. Lancet 340 8832 (1992) 1417-1418
27. Brinkman J.A., Rahmani M.Z., Jones W.E., Chaturvedi A.K., and Hagensee M.E. Optimization of PCR based detection of human papillomavirus DNA from urine specimens. J Clin Virol 29 4 (2004) 230-240
28. Payan C., Ducancelle A., Aboubaker M.H., Caer J., Tapia M., Chauvin A., et al. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. J Clin Microbiol 45 3 (2007) 897-901
29. Chew G.K., Jandial L., Paraskevaidis E., and Kitchener H.C. Pattern of CIN recurrence following laser ablation treatment: long-term follow-up. Int J Gynecol Cancer 9 6 (1999) 487-490
30. Bornstein J., Schwartz J., Perri A., Harroch J., and Zarfati D. Tools for post LEEP surveillance. Obstet Gynecol Surv 59 9 (2004) 663-668
31. Perrons C., Jelley R., Kleter B., Quint W., and Brink N. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J Clin Virol 32 4 (2005) 278-285
32. Lorincz A.T., Castle P.E., Sherman M.E., Scott D.R., Glass A.G., Wacholder S., et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360 9328 (2002) 228-229
33. Toye B., Woods W., Bobrowska M., and Ramotar K. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J Clin Microbiol 36 8 (1998) 2356-2358
34. Mahony J., Chong S., Jang D., Luinstra K., Faught M., Dalby D., et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 36 11 (1998) 3122-3126